InvestorsHub Logo
icon url

DewDiligence

07/07/23 5:15 PM

#2586 RE: DC15 #2585

Could be related to the HBV program. A few companies are testing combination regimens in HBV that include an immunotherapy component.
icon url

DewDiligence

08/07/23 9:22 PM

#2604 RE: DC15 #2585

That job ad you caught a few weeks ago makes more sense in light of the disclosure on today’s CC that ENTA has initiated discovery work in an undisclosed non-virology area.